Law360, New York (January 1, 2018, 3:04 PM EST) — The life sciences world is booming with questions over the future of patent challenges, whether opioid makers can survive a litany of deceptive marketing suits, and whether Allergan PLC’s bold move to sell some of its patents to a Native American …
